Zheng J - Search Results

1

PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α.

Hou P, Chen F, Yong H, Lin T, Li J, Pan Y, Jiang T, Li M, Chen Y, Song J, Zheng J, Bai J. Hou P, et al. Among authors: zheng j. J Exp Clin Cancer Res. 2019 Jul 10;38(1):301. doi: 10.1186/s13046-019-1312-y. J Exp Clin Cancer Res. 2019. PMID: 31291975 Free PMC article.

2

RUNX3 expression is lost in glioma and its restoration causes drastic suppression of tumor invasion and migration.

Mei PJ, Bai J, Liu H, Li C, Wu YP, Yu ZQ, Zheng JN. Mei PJ, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2011 Dec;137(12):1823-30. doi: 10.1007/s00432-011-1063-4. Epub 2011 Sep 16. J Cancer Res Clin Oncol. 2011. PMID: 21922326

3

BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.

Bai J, Mei PJ, Liu H, Li C, Li W, Wu YP, Yu ZQ, Zheng JN. Bai J, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2012 Jun;138(6):991-8. doi: 10.1007/s00432-012-1172-8. Epub 2012 Feb 24. J Cancer Res Clin Oncol. 2012. PMID: 22362300

4

RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.

Chen F, Bai J, Li W, Mei P, Liu H, Li L, Pan Z, Wu Y, Zheng J. Chen F, et al. Among authors: zheng j. PLoS One. 2013;8(2):e56241. doi: 10.1371/journal.pone.0056241. Epub 2013 Feb 14. PLoS One. 2013. PMID: 23457532 Free PMC article.

5

BRG1 is a prognostic marker and potential therapeutic target in human breast cancer.

Bai J, Mei P, Zhang C, Chen F, Li C, Pan Z, Liu H, Zheng J. Bai J, et al. Among authors: zheng j. PLoS One. 2013;8(3):e59772. doi: 10.1371/journal.pone.0059772. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533649 Free PMC article.

6

Cullin1 is a novel marker of poor prognosis and a potential therapeutic target in human breast cancer.

Bai J, Yong HM, Chen FF, Mei PJ, Liu H, Li C, Pan ZQ, Wu YP, Zheng JN. Bai J, et al. Among authors: zheng jn. Ann Oncol. 2013 Aug;24(8):2016-22. doi: 10.1093/annonc/mdt147. Epub 2013 Apr 16. Ann Oncol. 2013. PMID: 23592700 Free article.

7

RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer.

Bai J, Yong HM, Chen FF, Song WB, Li C, Liu H, Zheng JN. Bai J, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2013 Nov;139(11):1813-23. doi: 10.1007/s00432-013-1498-x. Epub 2013 Sep 4. J Cancer Res Clin Oncol. 2013. PMID: 24002642

8

The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer.

Xu W, Liu H, Song J, Fu HX, Qiu L, Zhang BF, Li HZ, Bai J, Zheng JN. Xu W, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2013 Nov;139(11):1845-52. doi: 10.1007/s00432-013-1500-7. Epub 2013 Sep 5. J Cancer Res Clin Oncol. 2013. PMID: 24005418

9

An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells.

Fang L, Cheng Q, Bai J, Qi YD, Liu JJ, Li LT, Zheng JN. Fang L, et al. Among authors: zheng jn. Mol Med Rep. 2013 Nov;8(5):1416-24. doi: 10.3892/mmr.2013.1680. Epub 2013 Sep 13. Mol Med Rep. 2013. PMID: 24042845

10

Diverse roles of C-terminal Hsp70-interacting protein (CHIP) in tumorigenesis.

Sun C, Li HL, Shi ML, Liu QH, Bai J, Zheng JN. Sun C, et al. Among authors: zheng jn. J Cancer Res Clin Oncol. 2014 Feb;140(2):189-97. doi: 10.1007/s00432-013-1571-5. Epub 2013 Dec 27. J Cancer Res Clin Oncol. 2014. PMID: 24370685 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,873 results

Search Page

Filters